IRCCS Istituto Delle Scienze Neurologiche di Bologna
Bologna, Italy
Research institute in Bologna
Padiglione G, Via Altura, 3, 40139 Bologna BO
About IRCCS Istituto Delle Scienze Neurologiche di Bologna
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
H. Lundbeck A/S
4
Azienda Usl di Bologna
2
Boehringer Ingelheim
2
GenSight Biologics
2
Santhera Pharmaceuticals
2
Takeda
2
Theravance Biopharma
2
Amgen
1
Boston Medical Center
1
CHDI Foundation, Inc.
1
ElectroCore INC
1
Clinical Trials at IRCCS Istituto Delle Scienze Neurologiche di Bologna
During the past decade, IRCCS Istituto Delle Scienze Neurologiche di Bologna conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
2012-07-01
2062-01-01
Recruiting
20,000
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
2015-01-21
2017-10-10
Completed
329
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
2016-02-23
2019-07-04
Completed
39
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)
2016-01-01
2018-12-01
Completed
37
RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks
2016-01-01
2017-03-01
Completed
285
Post Authorisation Safety Study With Raxone in LHON Patients
2016-09-01
2021-04-16
Completed
229
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
2016-05-01
2021-03-29
Completed
199
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" #1 sponsor was "H. Lundbeck A/S" with 4 trials, followed by "Azienda Usl di Bologna" with 2 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "GenSight Biologics" with 2 trials sponsored and "Santhera Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto Delle Scienze Neurologiche di Bologna"
#1 collaborator was "Heidelberg University" with 1 trials as a collaborator, "Ministero della Salute, Italy" with 1 trials as a collaborator and "Mortara Instrument Europe S.r.l." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at IRCCS Istituto Delle Scienze Neurologiche di Bologna
According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are
"Leber's Hereditary Optic Neuropathy (LHON)" (2 trials), "Migraine" (2 trials), "Optic, Atrophy, Hereditary, Leber" (2 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" in a lesser frequency.
Clinical Trials Intervention Types at IRCCS Istituto Delle Scienze Neurologiche di Bologna
Most popular intervention types in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are "Drug" (14 trials), "Device" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Eptinezumab" (3 trials), "GS010" (2 trials), "Idebenone" (2 trials) and "Sham Intravitreal Injection" (2 trials). Other intervention names were less common.
Clinical Trials Genders at IRCCS Istituto Delle Scienze Neurologiche di Bologna
The vast majority of trials in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are
22 trials for "All" genders.
Clinical Trials Status at IRCCS Istituto Delle Scienze Neurologiche di Bologna
Currently, there are NaN active trials in "IRCCS Istituto Delle Scienze Neurologiche di Bologna".
undefined are not yet recruiting,
7 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in IRCCS Istituto Delle Scienze Neurologiche di Bologna,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Istituto Delle Scienze Neurologiche di Bologna, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".